CASI Pharmaceuticals OverviewCASI Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for CASI.
Quarterly Other Income/Expense
-$206000.00
↓ 117.38% YoY
As of Sep 30, 2025
Annual Other Income/Expense (TTM)
-$2.04M
↓ 124.57% YoY
Trailing 12 months ending Sep 30, 2025